New Haven-based healthcare solutions company, Precipio, Inc., is at the forefront of diagnostic products, reagents, and services in the United States. With a focus on diagnostic blood cancer testing services, the company boasts an impressive range of offerings, including IV-Cell, a groundbreaking proprietary cell culture media that allows for the simultaneous culturing of four hematopoietic cell lineages, as well as HemeScreen, a suite of robust genetic diagnostic panels, and COVID-19 antibody tests. Additionally, Precipio, Inc. supplies its cutting-edge ICE- technology kits to bio-pharma customers, ensuring widespread access to its innovative products.
Precipio's ticker is PRPO
The company's shares trade on the NASDAQ stock exchange
They are based in New Haven, Connecticut
There are 11-50 employees working at Precipio
It is precipiodx.com/index.html
Precipio is in the Healthcare sector
Precipio is in the Diagnostic Substances industry
The following five companies are Precipio's industry peers: